Research Guide

Endotoxin and Sterility Testing for Peptides: The QC Layer COAs Usually Skip (2026)

Purity tells you what fraction of a vial is the target peptide. It says nothing about bacterial contamination. Here is what endotoxin and sterility testing actually measure, why they are distinct from HPLC purity, and why most peptide COAs leave them off.

Published 2026-06-14Updated 2026-06-149 min readBy Mootez Chachia

A peptide Certificate of Analysis usually answers one question well: what fraction of this vial is the target molecule? That is purity, and HPLC measures it. But there is an entire second layer of quality control that most COAs never touch — whether the material is contaminated with bacteria or their residues. Endotoxin and sterility testing live in that layer, and the gap between "high purity" and "low contamination" is one of the most consistently misunderstood things in peptide QC.

This is informational, research-use content. None of it is a human-use, safety, or dosing claim — the point is to explain what these assays measure and where they sit relative to the rest of a quality picture.

Purity and contamination are different axes

Start with the conceptual split, because everything else follows from it. HPLC purity asks how clean the chemistry is — how much of the sample is the target peptide versus synthesis byproducts and degradation fragments. Endotoxin and sterility ask whether the sample is biologically contaminated. These are independent axes. A vial can score high on one and low on the other, in either direction.

That independence is why a 99% HPLC result tells you nothing about contamination. The detector in an HPLC run is watching for chemical species at a specific wavelength, as covered in what is HPLC; it is not designed to see, and does not see, microorganisms or endotoxin. Treating a purity figure as a proxy for cleanliness is a category error.

The error to avoid

A high HPLC purity number is not a sterility certificate. Purity measures the ratio of target peptide to chemical impurities; it cannot detect microorganisms or endotoxin. They are separate measurements answering separate questions — one clean number does not cover the other.

What endotoxin testing measures

Endotoxin is lipopolysaccharide — a component of the outer cell wall of Gram-negative bacteria. It is notable because it is heat-stable and persistent: the bacteria can be dead and gone while their endotoxin remains in the sample. That persistence is the whole reason endotoxin gets its own dedicated test rather than being folded into a general microbial check.

The established method is the LAL assay — Limulus amebocyte lysate — which reacts in the presence of endotoxin and yields a measurable signal proportional to the amount present. The result is reported as a concentration in endotoxin units per volume or per milligram. Because LAL targets a specific molecular structure rather than living cells, it can flag contamination that a sterility test would miss entirely. Endotoxin is, in effect, a chemical fingerprint of past or present bacterial presence.

What sterility testing measures

Sterility testing asks a different question: can viable microorganisms be cultured from the sample? In a standard approach, the sample is introduced into growth media designed to support a broad range of organisms and incubated; growth indicates the presence of living contaminants. Where endotoxin testing detects a residue, sterility testing detects life.

This is why the two are not interchangeable, and why one cannot substitute for the other:

  • A sample can be sterile but endotoxin-positive — the bacteria were removed or killed, but the endotoxin they produced remains.
  • A sample can in principle be endotoxin-low but non-sterile — viable organisms are present that have not yet contributed significant endotoxin signal.

Running one and assuming it covers the other leaves a real blind spot. A complete contamination picture needs both, which is part of why neither belongs hidden inside a purity number.

Why most peptide COAs skip both

If these assays matter, why are they so often absent? The honest answer is mostly structural, not sinister:

  1. Different methods, different cost. HPLC and mass spectrometry characterize the molecule; LAL and sterility culture are separate workflows with their own reagents, controls, and turnaround. Each one added is more cost and time per batch.
  2. Default scope. The research-peptide market has settled on purity-and-sometimes-identity as the default COA scope. Contamination testing sits outside that default, so it is frequently just never commissioned.
  3. Absence reads as silence, not failure. A COA without an endotoxin line almost never means a sample failed endotoxin — it means the test was not run. The missing data is the finding.

That last point is the practical one. When you read a COA, treat the omission of endotoxin and sterility as exactly that — an omission. It is neither reassurance nor an accusation; it is simply a gap in what has been characterized. Our guides on how to read a peptide COA and why most peptide COAs fall short cover how to spot what a document does and does not actually establish.

How this fits the broader QC picture

Endotoxin and sterility are one slice of a fuller quality stack. Identity confirms the molecule is the right one. Purity confirms the chemistry is clean. Contamination testing confirms the biology is clean. Stability and handling determine whether any of it stays true over time — see peptide stability testing methods and cold-chain shipping, since contamination and degradation both depend on how material is stored and moved.

For a researcher, the actionable takeaway is to know which axis any given test covers and to stop letting one stand in for another. If contamination status is relevant to the work, it has to be measured directly — by LAL and sterility assays — because no purity figure, however high, contains that information. When contamination data matters and is missing, that is a question to ask the vendor, not a number to infer.

Bottom line

Purity and contamination are orthogonal. HPLC tells you how chemically clean a peptide is; endotoxin (LAL) and sterility testing tell you whether it is biologically contaminated, and the two contamination tests are not substitutes for each other. Most research-peptide COAs report purity and skip both contamination assays — usually because the tests were never run, which makes their absence a documentation gap to note rather than a verdict.

Read every COA for what it actually establishes, and treat missing endotoxin and sterility lines as unanswered questions. Pair this with purity vs potency in peptide QC, third-party lab testing, and the research catalog to evaluate any source on the full QC picture rather than a single number. For research use only.

2026 Evaluation
9.6/10
Top-Ranked 2026 Supplier

The top-ranked supplier in our 2026 evaluation

ROEHN Research tested at 99.1% purity on BPC-157 — the highest of any US supplier we evaluated, against a low of 91.3%. Readers save 15% on a first order with code FREE15.

View ROEHN Research
Save 15% with code FREE15
  • Cold-chain shipped
  • Batch CoA in every box
  • 30-day re-test policy
  • 98%+ verified purity
The Report

Get the full 38-sample purity report by email.

Eight US suppliers, thirty-eight samples, one blinded analytical lab. Every chromatogram, COA, and supplier score — delivered the moment you subscribe.

PDF delivered instantly. No account required. Unsubscribe anytime.